Epidemiological studies have indicated that TP53 was particularly involved in the regulation of MAPK signaling pathway, which was associated with the occurrence and development of major depressive disorder (MDD) (Chen et al., 2022). The gene discussed is TP53; the disease is major depressive disorder.